These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33007529)

  • 1. Evaluation of factors affecting the occurrence of second atypical fracture after bone union of the first atypical fracture.
    Tsuchie H; Miyakoshi N; Kasukawa Y; Nozaka K; Saito K; Kinoshita H; Kobatyashi M; Suzuki N; Aizawa T; Abe H; Maekawa S; Tomite T; Ono Y; Ouchi K; Shibata N; Nagahata I; Takeshima M; Akagawa M; Yuasa Y; Sato C; Shimada Y
    Bone; 2021 Feb; 143():115671. PubMed ID: 33007529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
    Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y
    Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
    J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
    Zhang HY; Weng HL; Li M; Zhang J
    Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture.
    Tsuchie H; Kasukawa Y; Nozaka K; Kinoshita H; Sasaki K; Aizawa T; Mita M; Ouchi K; Yuasa Y; Miura T; Tomite T; Maekawa S; Abe H; Akagawa M; Shibata N; Fujii M; Takeshima M; Inoue J; Saito H; Miyakoshi N
    Med Princ Pract; 2024; 33(1):10-20. PubMed ID: 38104544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.
    Byun SE; Lee KJ; Shin WC; Moon NH; Kim CH
    Osteoporos Int; 2023 Aug; 34(8):1323-1334. PubMed ID: 37095179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in "typical" atypical subtrochanteric femoral fracture: A proposed theory of atypical femoral fracture subtypes.
    Oh Y; Yamamoto K; Hashimoto J; Fujita K; Yoshii T; Fukushima K; Kurosa Y; Wakabayashi Y; Kitagawa M; Okawa A
    Bone; 2020 Aug; 137():115453. PubMed ID: 32470545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation.
    Shin WC; Moon NH; Jang JH; Seo HU; Suh KT
    Bone; 2019 Nov; 128():115033. PubMed ID: 31398503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
    Starr J; Tay YKD; Shane E
    Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.
    Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW
    Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of teriparatide on patients with atypical femur fractures: a systematic review and meta-analysis.
    Salamah HM; Abualkhair KA; Kamal SK; Mohamed HA; Alkheder A; Farho MA; Mistry D; Elbardesy H
    Arch Orthop Trauma Surg; 2024 Mar; 144(3):1091-1106. PubMed ID: 38135789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S
    Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teriparatide Does not Have Beneficial Effects on Bone Healing in Complete Atypical Femur Fractures.
    Song G; Jeong Y; Nam WD; Kim KH
    Calcif Tissue Int; 2024 Aug; 115(2):169-173. PubMed ID: 38907093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peri-implant atypical femoral fracture after nail or plate osteosynthesis.
    Kim JW; Oh CW; Park KH; Oh JK; Yoon YC; Kim JK
    J Orthop Sci; 2022 Jul; 27(4):866-875. PubMed ID: 34052080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential bone fragility of mid-shaft atypical femoral fracture: Biomechanical analysis by a CT-based nonlinear finite element method.
    Tano A; Oh Y; Fukushima K; Kurosa Y; Wakabayashi Y; Fujita K; Yoshii T; Okawa A
    Injury; 2019 Nov; 50(11):1876-1882. PubMed ID: 31519437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication management after intramedullary nailing of atypical fractures.
    Feron JM; Cambon-Binder A
    Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Atypical Femoral Fracture Cases Coupled in a Multicenter Study.
    Zenke Y; Ikeda S; Fukuda F; Tanaka M; Tanaka H; Hirano F; Sakai A
    J UOEH; 2016 Sep; 38(3):207-14. PubMed ID: 27627968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture Risk Following an Atypical Femoral Fracture.
    Bégin MJ; Audet MC; Chevalley T; Portela M; Padlina I; Hannouche D; Ing Lorenzini K; Meier R; Peter R; Uebelhart B; Rizzoli R; Ferrari S; Biver E
    J Bone Miner Res; 2022 Jan; 37(1):87-94. PubMed ID: 34668223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.